Advances in Hematological Malignancies
Recent years have witnessed remarkable advancements in the domain of hematological malignancies. Novel approaches such as targeted therapy, immunotherapies, and manipulation are revolutionizing the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering potential for more effective t